Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease

被引:50
|
作者
von Coelln, Rainer [1 ]
Shulman, Lisa M. [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Neurol, 110 S Paca St, Baltimore, MD 21201 USA
关键词
akinetic-rigid; heterogeneity; Parkinson disease; postural instability/gait difficulty; subtypes; tremor-dominant; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; LRRK2; G2019S; DIAGNOSTIC-CRITERIA; LEWY BODY; RISK; CLASSIFICATION; GAIT; AGE; NEUROPATHOLOGY;
D O I
10.1097/WCO.0000000000000384
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Recent studies on clinical, genetic and pathological heterogeneity of Parkinson disease have renewed the old debate whether we should think of Parkinson disease as one disease with variations, or as a group of independent diseases that happen to present with similar phenotypes. Here, we provide an overview of where the debate is coming from, and how recent findings in clinical subtyping, genetics and clinicopathological correlation have shaped this controversy over the last few years. Recent findings New and innovative clinical diagnostic criteria for Parkinson disease have been proposed and await validation. Studies using functional imaging or wearable biosensors, as well as biomarker studies, provide new support for the validity of the traditional clinical subtypes of Parkinson disease (tremor-dominant versus akinetic-rigid or postural instability/gait difficulty). A recent cluster analysis (as unbiased data-driven approach to subtyping) included a wide spectrum of nonmotor variables, and showed correlation of the proposed subtypes with disease progression in a longitudinal analysis. New genetic factors contributing to Parkinson disease susceptibility continue to be identified, including rare mutations causing monogenetic disease, common variants with small effect size and risk factors (like mutations in the gene for glucocerebrosidase) that fall in between the two other categories. Recent studies show some limited correlation between genetic factors and clinical heterogeneity. Despite some variations in patterns of pathology, Lewy bodies are still the hallmark of Parkinson disease, including the vast majority of genetic subgroups. Summary Evidence of clinical, genetic and pathological heterogeneity of Parkinson disease continues to emerge, but clearly defined subtypes that hold up in more than one of these domains remain elusive. For research to identify such subtypes, splitting is likely the way forward; until then, for clinical practice, lumping remains the more pragmatic approach.
引用
收藏
页码:727 / 734
页数:8
相关论文
共 50 条
  • [1] Parkinson disease GWAS The question of lumping or splitting is back again
    Simon-Sanchez, Javier
    Gasser, Thomas
    NEUROLOGY, 2015, 84 (10) : 966 - 967
  • [2] Clinical Subtypes of Parkinson's Disease
    van Rooden, Stephanie M.
    Colas, Fabrice
    Martinez-Martin, Pablo
    Visser, Martine
    Verbaan, Dagmar
    Marinus, Johan
    Chaudhuri, Ray K.
    Kok, Joost N.
    van Hilten, Jacobus J.
    MOVEMENT DISORDERS, 2011, 26 (01) : 51 - 58
  • [3] Genetic architecture of Parkinson's disease subtypes - Review of the literature
    Dulski, Jaroslaw
    Uitti, Ryan J.
    Ross, Owen A.
    Wszolek, Zbigniew K.
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [4] Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes
    Crosiers, David
    Theuns, Jessie
    Cras, Patrick
    Van Broeckhoven, Christine
    JOURNAL OF CHEMICAL NEUROANATOMY, 2011, 42 (02) : 131 - 141
  • [5] Replication and reliability of Parkinson's disease clinical subtypes
    Cash, Therese, V
    Lessov-Schlaggar, Christina N.
    Foster, Erin R.
    Myers, Peter S.
    Jackson, Joshua J.
    Maiti, Baijayanta
    Kotzbauer, Paul T.
    Perlmutter, Joel S.
    Campbell, Meghan C.
    PARKINSONISM & RELATED DISORDERS, 2024, 124
  • [6] Differentiating Parkinson Disease Subtypes Using Clinical Balance Measures
    Prime, Morgane
    McKay, J. Lucas
    Bay, Allison A.
    Hart, Ariel R.
    Kim, Chaejin
    Abraham, Amit
    Hackney, Madeleine E.
    JOURNAL OF NEUROLOGIC PHYSICAL THERAPY, 2020, 44 (01): : 34 - 41
  • [7] The clinical heterogeneity of Parkinson's disease and its therapeutic implications
    Greenland, Julia C.
    Williams-Gray, Caroline H.
    Barker, Roger A.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 328 - 338
  • [8] Parkinson disease clinical subtypes: key features & clinical milestones
    Campbell, Meghan C.
    Myers, Peter S.
    Weigand, Alexandra J.
    Foster, Erin R.
    Cairns, Nigel J.
    Jackson, Joshua J.
    Lessov-Schlaggar, Christina N.
    Perlmutter, Joel S.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (08): : 1272 - 1283
  • [9] Identifying genetic targets in clinical subtypes of Parkinson's disease for optimizing pharmacological treatment strategies
    Kong, Dewen
    Li, Cao
    Ma, Lingyan
    Du, Lida
    Jiang, Nan
    Zhao, Xiaoyue
    Zhang, Sen
    Zhao, Zhigang
    Fang, Lianhua
    Du, Guanhua
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [10] Rapid motor progression of Parkinson's disease associates with clinical and genetic variants
    Cao, Ling-Xiao
    Jiang, Yong
    Piao, Ying-Shan
    Huang, Yue
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (12): : 1503 - 1512